Patent details
EP1235830
Title:
PYRROLOÖ2,3-dÜPYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS
Basic Information
- Publication number:
- EP1235830
- PCT Application Number:
- PCT/IB/2000/001742
- Type:
- European Patent Granted for LU
- Legal Status:
- Expired
- Application number:
- EP009747387
- PCT Publication Number:
- WO/2001/042246
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PYRROLOÖ2,3-dÜPYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS
- French Title of Invention:
- COMPOSES A BASE DE PYRROLOÖ2,3-dÜPYRIMIDINE COMME INHIBITEURS DE PROTEINE KINASES
- German Title of Invention:
- PYRROLOÖ2,3-dÜPYRIMIDIN-VERBINDUNGEN ALS PROTEIN KINASEN HEMMER
- SPC Number:
-
Dates
- Filing date:
- 23/11/2000
- Grant date:
- 02/01/2004
- EP Publication Date:
- 02/01/2004
- PCT Publication Date:
- 14/06/2001
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/09/2002
- EP B1 Publication Date:
- 02/01/2004
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 23/11/2020
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/11/2000
-
-
- Name:
- Pfizer Products Inc.
- Address:
- Eastern Point Road, Groton, Connecticut 06340, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 07/01/2004
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- MUNCHHOF Michael J, Pfizer Global Research & Devp
- Address:
- United States (US)
2
- Name:
- BLUMENKOPF Todd Andrew, Pfizer Global Research Dv
- Address:
- United States (US)
3
- Name:
- FLANAGAN Mark Edward, Pfizer Global Res. & Develp
- Address:
- United States (US)
Priority
- Priority Number:
- 170179 P
- Priority Date:
- 10/12/1999
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
C07D 487/04;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 18/09/2019
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date |
Document type |
Number of pages |